Kenya: Bangladeshi Firm to Make Diabetes, Malaria Drugs in Kenya

One of Bangladesh's largest drugmakers, Square Pharmaceuticals, will start producing medicines at its multibillion production facility in Kenya in the next four months, targeting unmet demand in Kenya, Tanzania, Rwanda, Burundi, Uganda and South Sudan.

The pharmaceutical firm started the construction of a plant in 2018 at the tax-friendly export processing zones (EPZ) in Athi River with an initial investment of Ksh2.58 billion ($25 million) and now says it is ready to begin commercial production after the completion of the factory.

"We will hopefully be able to start manufacturing at the plant by July or August," Tapan Chowdhury, managing director of Square Pharmaceuticals, was quoted saying this week by local Bangladeshi media.

Trial production at the new facility is expected to begin on July 31. Among the drugs lined for production are drugs for diabetes, malaria, cardiovascular diseases and anti-psychotic diseases.

"The drugs that we intend to manufacture are branded generics that are on the World Health Organization pre-qualified drugs list that the organisation has listed for treating priority diseases," said Mr Chowdhury in 2018 during the groundbreaking.

In Bangladesh, the firm produces 637 pharmaceuticals exported to over 43 countries.

The Kenya plant is expected to minimise the country's dependency on pharmaceutical imports and reduce the cost of drugs. Kenya imports medicines worth $600 million annually, according to official statistics.

Apart from lowering the cost of drugs, it is expected to increase access to genuine drugs given the challenge of counterfeits.

More From: East African

Don't Miss

AllAfrica publishes around 900 reports a day from more than 130 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.

X